Ownership, Partner Choice and Reputation
Ownership means decision-making power as well as a share of benefits. As individuals along the supply chain are all product owners and thus stakeholders in completed products, taking part in key decisions proportional to their ownership, through voting based on NFT shards. Each stage of the supply chain is competitive, with different entities jostling to get their share of the end product. Rejuve Product NFT holders democratically choose network partners to take on the next stage of the process. Token holders will be able to vote through the Rejuve app or website. The decision-making process can be as small as a single user choosing a supplement to buy or as large as all owners of a product at the phase 1 stage choosing the pharmaceutical company to take their co-owned product to FDA approval.
Stakeholders who vote on the partner for the next stage have access to a reputation system to help them judge candidates:
App users/patients in the network have reputations that are based on the quality of the data they have submitted in the past, which is based mainly on verifications, statistics, and an AI assignment of credit.
Labs (or researchers) have reputations based mainly on involvement in past successful projects and user opinions based on ethics as reflected in the projects they have participated in.
Institutional review boards’ (IRB) reputation is based on the legitimacy of their arguments as judged by regulatory agencies. This reputation will incentivize labs to choose a successful IRB board to approve their ideas so that they will continue to the next phase.
Longevity clinics will have reputations based on past successful projects and user opinions. Users may have opinions of longevity clinics based on the quality of supplements and treatments they have purchased.
All of these may have opinions of the best pharmaceutical companies to sell their collective product to based on ethics, a good record on obtaining FDA approval, compensation and other factors. The reputation of network entities is accrued over time and calculated from voluntary five-star recommendations weighted in proportion to product ownership. While the market is young, Rejuve Network will perform some manual curation of network partners, but as the network grows, the reputation system will take over.
Ownership also means getting a share of the proceeds of sales, and so we ensured that with every final product bought in tokens, that the owners get their share of tokens.
However, we also want the public to be able to buy treatments with fiat (to remove the friction created by requiring crypto tokens). To accomplish this goal, we allow approved distributors, in network pharmacies, to purchase the drug in tokens and to sell it in fiat, after Network members have had first and exclusive access to the treatment for a period of time.
Last updated